InspireMD Adds Two Directors to Board

Ticker: NSPR · Form: 8-K · Filed: Apr 2, 2024 · CIK: 1433607

Inspiremd, INC. 8-K Filing Summary
FieldDetail
CompanyInspiremd, INC. (NSPR)
Form Type8-K
Filed DateApr 2, 2024
Risk Levellow
Pages5
Reading Time6 min
Key Dollar Amounts$0.0001
Sentimentneutral

Sentiment: neutral

Topics: board-of-directors, governance, personnel-change

TL;DR

InspireMD adds Eyal Leibovitz and Yishai Ben-Dor to its board, effective April 2, 2024.

AI Summary

InspireMD, Inc. announced on April 2, 2024, a change in its board of directors. The company elected two new directors, Mr. Eyal Leibovitz and Mr. Yishai Ben-Dor, to its Board of Directors. This appointment is effective immediately and aims to strengthen the company's governance and strategic direction.

Why It Matters

The addition of new directors can signal a shift in company strategy or governance, potentially impacting future performance and investor confidence.

Risk Assessment

Risk Level: low — This filing is a routine corporate update regarding board composition and does not involve significant financial transactions or operational changes.

Key Players & Entities

FAQ

Who were the individuals elected to the InspireMD, Inc. Board of Directors?

Mr. Eyal Leibovitz and Mr. Yishai Ben-Dor were elected to the Board of Directors of InspireMD, Inc.

When was the election of the new directors effective?

The election of Mr. Eyal Leibovitz and Mr. Yishai Ben-Dor was effective as of April 2, 2024.

What is the primary purpose of this 8-K filing?

This 8-K filing reports the election of two new directors to the company's Board of Directors.

What is InspireMD, Inc.'s principal executive office address?

InspireMD, Inc.'s principal executive office is located at 4 Menorat Hamaor St., Tel Aviv, Israel, 6744832.

What is InspireMD, Inc.'s telephone number?

InspireMD, Inc.'s telephone number is (888) 776-6804.

Filing Stats: 1,533 words · 6 min read · ~5 pages · Grade level 14.1 · Accepted 2024-04-02 09:14:08

Key Financial Figures

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. INSPIREMD, INC. Date: April 2, 2024 By: /s/ Craig Shore Name: Craig Shore Title: Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing